Homocysteine

Clinics in Laboratory Medicine

Volumn 26, Issue 3, 2006, Pages 591-609

  Maron, Bradley A ^a   Loscalzo, Joseph ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ACCURACY; ARTERY DISEASE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; ELECTROCHEMICAL DETECTION; FLUORESCENCE; GAS LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOASSAY; LABORATORY TEST; MASS SPECTROMETRY; NEURAL TUBE DEFECT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; URINALYSIS; VASCULAR DISEASE;

ANIMALS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HOMOCYSTEINE; HUMANS; IMMUNOASSAY;

EID: 33747812918     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2006.06.008     Document Type: Review

References (105)

1. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke; a meta-analysis. JAMA 288 (2002) 2015-2022
2. Bostom A., Silbershatz H., Rosenberg I., et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159 (1999) 1077-1080
3. Refsum H., Smith D., Ueland P., et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50 1 (2004) 3-32
4. Champe P., and Harvey R. Amino acids: metabolism of carbon skeletons. In: Champe P., and Harvey R. (Eds). Lippincott's illustrated reviews: biochemistry. 2nd edition (1987), J.B. Lippincott, Philadelphia (PA) 248-249
5. McCully K. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56 (1969) 111-128
6. Cattaneo M. Hyperhomocysteinemia, atherosclerosis, and thrombosis. Thromb Haemost 81 (1999) 165-176
7. Boushey C., Beresford S., Omenn G., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
8. Al-Shaer M., Raghuveer G., Browning R., et al. Effect of hyperhomocysteinemia induced by methionine administration on flow-mediated dilatation of the brachial artery in healthy subjects. Am J Cardiol 95 3 (2005) 428-430
9. Ueland P. Homocysteine species as components of plasma redox thiol status. Clin Chem 41 (1995) 340-342
10. Ueland P., Refsum H., Stabler S., et al. Total homocysteine in plasma or serum. Methods and clinical applications. Clin Chem 39 (1993) 1764-1779
11. Rasmussen K., and Møller J. Total homocysteine determination in clinical practice. Ann Clin Biochem 37 (2000) 627-648
12. Jacques P., Rosennberg I., Rogers G., et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the Third National Health and Nutrition Examination Survey. Am J Clin Nutr 69 (1999) 482-489
13. Must A., Jacques P., Rogers G., et al. Total homocysteine concentrations in children and adolescents: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Nutr 133 (2003) 2643-2649
14. Bostom A., and Culleton B. Hyperhomocysteinemia and chronic renal disease. J Am Soc Nephrol 10 (1999) 891-900
15. Cooke J., Stamler J., Andon N., et al. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 259 (1990) H804-H812
16. Vita J., Treasure C., Nabel E., et al. Coronary vasomotor response to acethylcholine relates to risk factors for coronary artery disease. Circulation 81 (1990) 491-497
17. Bellamy M., McDowell I., Ramsey M., et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98 (1998) 1848-1852
18. Chambers J., Obeid O., and Kooner J. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb Vasc Biol 19 (1999) 2922-2927
19. Lentz S., Sobey C., Piegors D., et al. Vascular dysfunction in monkeys with diet induced hyperhomocysteinemia. J Clin Invest 98 (1996) 24-29
20. Ungvari Z., Pacher P., Rischak K., et al. Dysfunction of nitric oxide mediation in isolated rat arterioles with methioinine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 19 (1999) 1899-1904
21. Weiss N., Zhang Y., Heydrick S., et al. Overexpression of cellular glutathione peroxidaase rescues homocysteine-induced endothelial dysfunction. Proc Natl Acad Sci USA 98 (2001) 12503-12508
22. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 98 (1996) 5-7
23. Weiss N., Zhang Y., and Loscalzo J. Homocysteine impairs cellular glutathione peroxidase expression and promotes endothelial dysfunction in an animal model of hyperhomocysteinemia. Circulation 102 (2000) II-238 [abstract]
24. Forgione M., Cap A., Liao R., et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 106 (2002) 1154-1158
25. Schnabel R., Lackner K., Rupprecht H., et al. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction. J Am Coll Cardiol 45 (2005) 1631-1637
26. Handy D., Zhang Y., and Loscalzo J. Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem 280 (2005) 15118-15125
27. Hoffman M., Lalla E., Lu Y., et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 197 (2001) 675-683
28. Zhou J., Møller J., Ritskes-Hoitinga M., et al. Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice. Atherosclerosis 168 (2003) 255-262
29. Zhou J., Werstuck G., Lhoták S., et al. Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice. Circulation 110 (2004) 207-213
30. Frantzen F., Faaren A., Alfheim I., et al. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 44 (1998) 311-316
31. Ludbrook J. Statistical techniques for comparing measures and methods of measurement: a critical review. Clin Exp Pharm Phsyiol 29 (2002) 527-536
32. Møller J., Rasmussen K., and Christensen L. External quality assessment of methylmalonic acid and total homocysteine. Clin Chem 45 (1999) 1536-1542
33. Refsum H., Ueland P., and Svardal A. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 35 (1989) 1921-1927
34. Ubbink J. Assay methods for the measurement of total homocysteine in plasma. Semin Thromb Hemost 26 (2000) 233-239
35. Wilcken D., and Gupta V. Cysteine-homocysteine mixed disulphide: differing plasma concentrations in normal men and women. Clin Sci (Lond) 57 (1979) 211-215
36. Jacobsen D., Gatautis V., and Green R. Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection. Anal Biochem 178 (1989) 208-214
37. Baeyens W., Van der Weken G., Lin Ling B., et al. HPLC determination of N-acetylcysteine in pharmaceutical preparations after pre-column derivatization with thiolyte RMB using fluorescence detection. Anal Lett 21 (1988) 741-757
38. Ubbink J. Assay methods for the measurement of total homocysteine in plasma. Semin Thromb Hemost 26 (2000) 233-241
39. Maddocks J., and MacLachlan J. Application of new fluorescent thiol reagent to diagnosis of homocystinuria. Lancet 338 (1991) 1043-1044
40. Cavrini V., Gatti R., Roveri P., et al. Analysis of thios by HPLC after fluorescent prelabelling with 4-(6-methylnaphthalen-2-yl)-4-oxobuten-2-oic acid. Chromatographia 27 (1989) 185-190
41. Evans R., Shaten B., Hempel J., et al. Homocysteine and risk of cardiovascular disease in the multiple risk factor intervention trial. Arterioscler Thromb Vasc Biol 17 (1997) 1947-1953
42. Nygård O., Nordrehaug J., Refsum H., et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
43. Kuo K., Still R., and Cale S. Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 43 (1997) 1653-1655
44. Vester B., and Rasmussen K. High performance liquid chromatrography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 29 (1991) 549-554
45. Dudman N., Guo X., Crooks R., et al. Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2oxa-1, 3diazole-4-sulfonic acid derivative, and use of appropriate calibrators. Clin Chem 42 (1996) 2028-2032
46. Accinni R., Campolo J., Bartesaghi S., et al. High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. J Chromatogr A 828 (1998) 397-400
47. Stabler S., Marcell P., Podell E., et al. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 81 (1988) 466-474
48. Amores-Sánchez M., and Medina M. Methods for the determination of plasma total homocysteine: a review. Clin Chem Lab Med 38 (2000) 199-204
49. Verhoef F., Hennekens C., Manilow R., et al. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 25 (1994) 1924-1930
50. Wu L., Wu J., Hunt S., et al. Plasma homocysteine as a risk factor for early familial coronary artery disease. Clin Chem 40 (1994) 552-561
51. Rabenstein D., and Yamashita G. Determination of homocysteine, penicillamine, and their symmetrical and mixed disulfides by liquid chromatography with electrochemical detection. Anal Biochem 180 (1989) 259-263
52. Smolin L., and Schneider J. Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection. Anal Biochem 168 (1988) 374-379
53. Martin S., Tsakas-Ampatzis I., Bartlett W., et al. Measurement of plasma homocysteine by HPLC with coulometric detection. Clin Chem 45 (1999) 150-152
54. Evrouski J., Callaghan M., and Cole D. Determination of homocysteine by HPLC with pulsed integrated amperometry. Clin Chem 41 (1995) 757-758
55. Stabler S., Marcell P., Podell E., et al. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 162 (1987) 185-196
56. Allen R., Stabler S., Savage D., et al. Metabolic abnormalities in cobalamin (vitamin B-12) and folate deficiency. FASEB J 7 (1993) 1344-1353
57. Savage D., Lindenbaum J., Stabler S., et al. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 96 (1994) 239-246
58. Pfeiffer C., Huff D., Smith S., et al. Comparison of plasma total homocysteine measurements in 14 laboratories: an international study. Clin Chem 45 (1999) 1261-1268
59. Kang S., Kim J., and Chung D. Determination of homocysteine and other thiols in human plasma by capillary electrophoresis. J Pharm Biomed Anal 15 (1997) 1435-1441
60. Vecchione G., Margaglione M., Grandone E., et al. Determining sulfur-containing amino acids by capillary electrophoresis: a fast novel method for total homocysteine in human plasma. Electrophresis 20 (1999) 569-574
61. Causse E., Terrier R., Champagne S., et al. Quantitation of homocysteine in human plasma by capillary electrophoresis and laser-induced fluorescence detection. J Chromatogr 817 (1998) 181-185
62. Zinellu A., Sotgia S., Posadino A., et al. Highly sensitive simultaneous detection of cultured cellular thiols by laser induced fluorescence-capillary electrophoresis. Electrophoresis 24 (2003) 2796-2804
63. Magera M., Lacey J., Casetta B., et al. Method for determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 45 (1999) 1517-1522
64. McCann S., Gillingwater S., Keevil B., et al. Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method. Ann Clin Biochem 40 pt 2 (2003) 161-165
65. Schipchandler M., and Moore E. Rapid, fully automated measurement of plasma homocysteine with the Abbott IMx analyzer. Clin Chem 41 (1995) 991-994
66. tm fluorescence polarization immunoassay and the Bio-Rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatography. Ann Clin Biochem 37 (2000) 194-198
67. Mourvaki E., Ferrante F., Chirarduzzi A., et al. Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease. Am J Clin Pathol 124 (2005) 675-681
68. Ubbink J., Becker P., Delport R., et al. Variability of post-methionine load plasma homocysteine assays. Clin Chem Acta 330 (2003) 111-119
69. Tropodi A., Chantarangkul V., Lombardi R., et al. Multicenter study of homocysteine measurement-performance characteristics of different methods, influence of standards on interlaboratory agreement of results. Thromb Haemost 87 (2002) 921-922
70. Marangon K., O'Byrne D., Devaraj S., et al. Validation of an immunoassay for measurement of plasma total homocysteine. Am J Clin Pathol 112 (1999) 757-762
71. Lonati S., Noembrino C., Ippolito S., et al. Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer. Clin Chem Lab Med 42 (2004) 228-234
72. Hanson N., Eckfeldt J., Schwichtenberg K., et al. Interlabortory variation of plasma total homocysteine measurements: results of three successive homocysteine proficiency testing surveys. Clin Chem 48 (2002) 1539-1545
73. Ubbink J., Delport R., Riezler R., et al. Comparison of three different plasma homocysteine assays with gas chromatography-mass spectrometry. Clin Chem 45 (1999) 670-675
74. Sassi S., Cosmi B., Palareti G., et al. Influence of age, sex, and vitamin status on fasting and post-methionine load plasma homocysteine levels. Haematologica 87 (2002) 957-964
75. Candito M., Bedoucha P., Gibelin P., et al. Fasting, postprandial, and post-methionine load homocysteinaemia and methylenetetrahydrofolate reductase polymorphism in vascular disease. J Inherit Metab Dis 22 (1999) 588-592
76. Tsai M., Welge B., Hanson N., et al. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery disease. Atherosclerosis 142 (1999) 163-170
77. Quest Diagnostics Interpretive Guide. The quest diagnostics information for the health care professional page. Available at: http://questdiagnostics.com/hcp/intguide/hcp_ig_main.html. Accessed February 12, 2006.
78. Selhub J., Jacques P., Rosenberg I., et al. Serum total homocysteine concentrations in the third national health and nutrition examination survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 131 (1999) 331-339
79. Fiskerstrand T., Refsum H., Kvalheim G., et al. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 39 (1993) 263-271
80. de Bree A., Verschuren W., Blom H., et al. Association between B vitamin intake and plasma homocysteine concentrations in the general Dutch population aged 20-65 y. Am J Clin Nutr 73 (2001) 1027-1033
81. Jacques P., Selhub J., Bostom A., et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340 (1999) 1449-1454
82. Mudd S., Havlik R., Levy H., et al. A study of cardiovascular risk in heterozygotes for homocystinuria. Am J Hum Genet 33 (1981) 883-893
83. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia. N Engl J Med 324 (1991) 1149-1155
84. Graham I., Daly L., Refsum H., et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 277 (1997) 1775-1781
85. Soedamah-Muthu S., Chaturvedi N., Teerlink T., et al. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross sectional nested case-control study. J Intern Med 258 (2005) 450-459
86. Sundstrom J., and Vasan R. Homocysteine and heart failure: a review of investigations from the Framingham Heart Study. Clin Chem Lab Med 43 10 (2005) 987-992
87. Danesh J., and Lewington S. Plasma homocysteine and coronary heart disease. J Cardiovasc Risk 5 (1998) 229-232
88. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 16 (2002) 2015-2022
89. Omland T., Samuelsson A., Hartford M., et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 160 (2006) 1834-1840
90. Seshardi S., Beiser A., Selhub J., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346 (2002) 476-483
91. van Meurs J., Dhonukshe-Rutten R., Pluijm S., et al. Homocystein levels and the risk of osteoporotic fracture. N Engl J Med 350 (2004) 2033-2041
92. Levine J., Sela B., Osher Y., et al. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1181-1191
93. Hall F. Solehdin, Folic acid for the prevention of congenital anomalies. Eur J Pediatr 157 6 (1998) 445-450
94. Wald N. Folic acid and the prevention of neural-tube defects. N Engl J Med 350 (2004) 101-103
95. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentration of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82 (2005) 806-812
96. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 151 2 (2006) 282-287
97. Toole J., Malinow M., Chambless L., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291 (2004) 565-575
98. Bønaa K.H., Njølstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med (2006) 1578-1588
99. Guo H., Lee J., Xing Y., et al. Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation. Acta Cardiol 59 5 (2004) 503-506
100. Woo K., Chook P., Chan L., et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 112 7 (2002) 535-539
101. Woo K., Chook P., Lolin Y., et al. Folic acid improves arterial endothelial function in adulst with hyperhomocysteinemia. JACC 34 7 (1999) 2002-2006
102. Perini F., Galloni E., Bolgan I., et al. Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease. Neurol Sci 26 (2005) 310-318
103. Sacco R., Anand K., Lee H., et al. Homocysteine and the risk of ischemic stroke in a tirethnic cohort: the northern Manhattan study. Stroke 35 (2004) 2263-2269
104. Taylor L., Moneta G., Sexton G., et al. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 29 1 (1999) 19-21
105. Diehm C., Schuster A., Allenberg J., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172 1 (2004) 95-105